Then reassess
PMID 12087074
Additionally, GLP-1R agonists inhibit tau protein hyperphosphorylation, promote the release of brain-derived neurotrophic factor, and reduce neuroinflammatory responses by inhibiting microglial and astrocyte activation [55,56,57]
Glutamate is the most abundant neurotransmitter in the brain
Studies suggest that LPCAT3 suppresses ACSL4 in IL-1-stimulated chondrocytes, thereby inhibiting ferroptosis and protecting mitochondria, but in other settings, it may exacerbate ferroptotic lipid remodeling (76)
Adam Auton, geneticist at 23andMe, to break down a brand new paper using data from over 27,000 people that identified specific genetic variants linked to how well GLP-1 medications work and how likely someone is to experience side effects